Background: Ovarian cysts are commonly observed pathologies, which interfere with normal cyclic activity and adversely affect fertility in cows. Beta-carotene is effective in the reduction of reproductive problems by inducing the natural defence mechanisms of the body. There are several methods that can be used for the treatment of ovarian cysts. The separate and combined use of GnRH and PGF2α commonly uses in the treatment of ovarian cysts. Therefore, in the presented study the effects of Beta-carotene (βC) addition for the treatment of ovarian cysts either with GnRH solely or GnRH and PGF2α in combination on the fertility parameters of dairy cows were investigated. Materials, Methods & Results: Seventy-six Holstein Friesian cows having ovarian cysts diagnosed by ultrasonography (USG) were divided into three groups. Cows in Group I (GI, n = 27), were injected with GnRH (Buserelin acetate, 5 mL, im), PGF2α (Tiaprost-trometamol, 5 mL, im) and βC (20 mL/cow, into 4 regions by im route). In Group II (GII, n = 25) GnRH (Buserelin acetate, 5 mL, im) and PGF2α (Tiaprost-trometamol, 5mL, im) were administrated while GnRH (Buserelin acetate, 5 mL, im) solely in Group III (GIII, n = 24). Cysts were monitored via USG, and blood samples were collected on the on day of treatment (day 0) and on the 7th and 14th days following the administrations. Cows shoving oestrous were inseminated and pregnancy diagnoses were performed on the 40th day following insemination. Treatment results showed that there were statistically no significant differences between GI and GII (P > 0.05). Only numerical difference obtained in time from therapy to pregnancy and overall pregnancy index (P > 0.05). Overall pregnancy rate (85 %), first service pregnancy rates (40 %) and overall pregnancy index (2.11) in GI were found significantly higher than GIII (53.3 %; 20 %; 4.12) [P < 0.05]. No significant difference was observed in progesterone (P4) levels between the groups (P > 0.05). It was found that βC administrations significantly increased βC levels in GI than GII and GIII on the 7 th and 14 th days (P < 0.05). Discussion: One of the most common problems encountered in modern dairy production is the development of ovarian cysts. Treatments for ovarian cyst are numerous and variable, and have changed considerably over the years. In the present study, GnRH and PGF2α were administered together as a combination, and as a result of this combined use, higher percentages were obtained for both pregnancy rate and fertility parameters in GI and GII, in comparison to the group administered with GnRH alone (GIII). Better outcome from combination therapy (GnRH and PGF2α) may be due to the fact that luteal thickening in the walls of cysts was determined by ultrasonography, but P4 values were not identified immediately and the treatments were not categorized in accord with these values. No statistically significant differences were determined between GI and GII concerning the fertility parameters investigated, however numerical and proportional differences were observed. βC levels were significantly higher on day 7 and 14 after treatment in GI which were administered βC additionally to the treatment protocol for ovarian cysts. This statistical difference suggests that administration of βC in combination therapy is also effective in the treatment of ovarian cysts. In conclusion, it was determined that high pregnancy rates were obtained by the combined treatment of ovarian cysts (GnRH + PGF2α) and number of inseminations per conception were at desired limits. Better percentile and numerical fertility parameters were achieved in the group, which additionally received βC, high numbers of infertility cases, βC supplementation could be a viable option for treatment.
INTRODUCTION
Ovarian cysts are commonly observed pathologies, which interfere with normal cyclic activity and adversely affect fertility in cows. Due to the prolonged calving interval, culling of the animals and veterinary medical costs, ovarian cysts have economic significance for dairy industry [46] . It is reported that the incidence of ovarian cysts in herds ranges between 6 % and 30 % [25, 40, 42] .
Bovine ovarian cysts are fluid-filled, anovulatory, pathological follicles with a diameter of ≥ 25 mm, which are observed in either one or both of the ovaries and persist for more than 10 days in the absence of active luteal tissue [40, 42, 46] . It is generally accepted that cystic follicles develop as a result of the functional disorders of the hypothalamo-hypophyseal-ovarian axis [25, 31, 46] . Local factors, including among others, nutrition, uterine infections, stress and genetics are involved in the development of this disorder [25, 31, 46] . One of the major factors involved is βC deficiency [10, 13] . Beta-carotene as the precursor of Vitamin A, βC is effective in the reduction of reproductive problems by inducing the natural defence mechanisms of the body through lymphocyte proliferation and phagocytosis [12] . The gonadotropin-releasing hormone (GnRH), intravaginal progesterone devices (PRID ® or CIDR) and prostaglandin F2α have been commonly used in the treatment of ovarian cysts [7, 31, 40] . Successful fertility results have been reported when GnRH administrations were combined with βC, used for the early postpartum treatment of ovarian cysts [1] .
This study was designed to investigate the effects of separate or combined use of GnRH and PGF2α or the addition of Beta-carotene to this regimen, for the treatment of ovarian cysts, on fertility parameters.
MATERIALS AND METHODS

Animals
Seventy-six Holstein-Friesian dairy cows, aged between 3 to 7 years, have constituted the animal material of the study. The study was conducted at a private dairy farm, where the cows were housed in semi-open free-stall barns throughout the year and fed on a total mixed ration (corn and grass silage, hay, triticale, canola and a balanced grain ration) twice a day.
Study design
It was determined that the body condition scores of the animals included in the study ranged between 3.0 and 3.5 (5 point-scale) and that their average milk yield per lactation ranged from 7.110 to 11.000 kg. Throughout the herd, in which regular postpartum examinations were held, the animals that did not show oestrus between days 25-35, 45-50 and 60-70 postpartum and those that either showed oestrus or did not conceive after being inseminated were allocated for the further examinations with ultrasonography (USG).
The animals were examined for the presence of ovarian cysts by USG (linear probe; 5.0 Mhz, Agroscan ® L) 1 and were assigned to three groups on the basis of the results obtained (diameter of follicular structure ≥ 2.5 cm; for a minimum ten days in the absence of a luteal tissue) [42, 46] . The cows in Group I (GI, n = 27) were administered with GnRH (5 mL/ cow im) [ 4 . GnRH (Buserelin acetate; Buserin ® , 5 mL/cow im) and PGF2α (Tiaprost-trometamol; Iliren ® , 5 mL/cow, im) were administrated to the animals in Group II (GII, n = 25). Group III (GIII, n = 24) was maintained for control purposes and received only GnRH (Buserelin acetate; Buserin ® , 5 mL/cow im). The progression of the ovarian cysts was checked on the day of administration (day 0) and once a week for the following two weeks (days 7 and 14) [by USG].
The size and type (luteal, follicular) of the ovarian cysts detected at examination were written down in follow-up forms. The animals, which were having signs of oestrus as a result of cystic regression, were inseminated. Pregnancy examinations were performed 40-45 days after insemination by transrectal ultrasonography. The overall pregnancy rates were determined according to the results of the three inseminations performed in the postpartum period. Cows, displaying signs of oestrus after the third insemination, were considered as non-pregnant.
Cysts with > 3 mm wall thickness and > 3.18 nmol/L serum progesterone (P4) were considered to be luteal cysts, whilst cysts that had a thinner wall and lower serum P4 levels were considered to be follicular cysts [23, 33] .
For the assessment of treatment efficiency, fertility parameters including the time from therapy to first service (day), time from therapy to pregnancy (day), as well as the overall pregnancy rate (pregnancy rates after a maximum of three consequent insemina-tions, %), first service pregnancy rates (pregnancy rates after first insemination, %), insemination index, the pregnancy index (number of services per pregnancy) and overall pregnancy index (number of inseminations in all animals/pregnant animals) and treatment success rate (%) were investigated [35] .
Blood sampling and testing
In order to measure the progesterone (P4) and βC levels, 10 mL blood samples were taken from the jugular vein of each animal both before treatment and on the control days after treatment. The blood samples were centrifuged at 850 g for 15 min and the sera extracted were stored at -20°C until being analysed.
Beta-carotene concentrations were determined using the spectrophotometric method [34] . Serum P4 concentrations were measured with the electrochemical immunoassay (Düzen Laboratory Group)5 [41] .
Statistical analysis
The statistical analysis were made by using the SPSS® (Statistical Package for the Social Sciences, 16.0) 6 software. The homogeneity of the groups was investigated with the Kolmogorov-Smirnov test. The groups displaying homogenous distribution were compared with the analysis of variance (Tukey's test). On the other hand, the groups not displaying a homogenous distribution were investigated by using the MannWhitney U test, and those that were determined to be different were compared with Wilcoxon's test. A level of P < 0.05 was considered statistically significant.
RESULTS
During the study period, 76 of investigated 557 cows were determined to have ovarian cysts and were treated. Of the cysts detected at examination, 31 were follicular cysts (40.8 %) and 45 (59.2%) were luteal cysts. The incidence of ovarian cysts in the herd was ascertained to be 13.6 %. Ultrasonography (wall thickness ≤ 3 mm; > 3 mm) and P4 measurements (> 3.18 nmol/L) showed that the percentage of the luteal cysts was higher than follicular cysts (Table 1) .
In 23 of 27 cows in GI regression of the cysts were determined and 20 (74%) cows showed oestrus. In GII 20 (80%) of 25 cows with ovarian cysts showed oestrus and inseminated. In GIII, out of the 24 cows with an ovarian cyst, 15 (62.5%) were determined to show oestrus and were inseminated. Regression of the cysts after treatment was observed in 3 of 7 cows (42.85%) in GI, 2 of 5 cows (40 %) in GII and 3 of 9 (33.3%) in GIII in non-inseminated cows ( Table 2 ). No significant difference was determined between the fertility results of GI and GII (P > 0.05). Only numerical differences were observed in terms of time from therapy to pregnancy (DT-PD) and overall pregnancy index (P > 0.05). It was determined that the overall pregnancy rates (OPR), overall pregnancy index (OPI), and treatment success rate (TSR) of GI significantly differed from the same parameters of GIII (P < 0.05). Numerical differences were determined between GI and GII in terms of all evaluated fertility parameters. It was determined that lower number of inseminations were performed in GI for the conception of the animals ( Table 3 ).
In GI serum βC concentrations increased till to the last sampling on day 14 after treatment. On days 7 and 14 after treatment serum βC levels of GI were significantly higher than GII and GIII (P < 0.05) [ Table 4 ].
The assessment of the P4 levels of the inseminated cows demonstrated that, in GI, the activity of the ovaries with cysts producing low P4 levels on day 0 (≤ 3.18 nmol/L) and high P4 levels on day 7 (6.18 -24.63 nmol/L) was 75% (associated with decrease / increase in P4 levels), whilst in the other groups the ovarian activity rate was determined as 40% on day 7 (P < 0.05). In 60% of the cows in GII and GIII regression of the ovarian cysts prolonged to a period of 14 days (Table 5 ). ) in the same row are significantly different (P < 0.05). ) in the same row are significantly different (P < 0.05). ) in the same row are significantly different.
DISCUSSION
One of the most common problems encountered in modern dairy production is the development of ovarian cysts. Researches have shown that the incidence of ovarian cysts in dairy herds ranges between 6% and 30% [25, 40, 42] . In the present study, the incidence of ovarian cysts in the herd was determined to be 13.6%, and thus, was found similar to the findings of the other researchers. Several factors affect the incidence of ovarian cysts, including environmental factors, season, herd management, and the age, milk yield, body condition score and uterine diseases of the animal [11, 42] . It was reported previously, incidence of luteal cysts ranges between 15.4% and 39.85% as well as it is between 60.1% and 84.6% in follicular cysts [19, 26] . Contrary to the above mentioned studies, the incidence of luteal cysts (59.2%) was found to be higher than follicular cysts (40.8%) in the present study. As it was aimed to provide uniform feeding and housing conditions, the present study was performed at a single herd. Therefore, the incidences determined for luteal and follicular cysts in the present study should be considered as specific findings valid for this particular herd.
Treatments for ovarian cyst are numerous and variable, and have changed considerably over the years [31] . Human chorionic gonadotropin (hCG) and GnRH have been used for the treatment of ovarian cysts since the 1970s [31] . Pregnancy rate obtained after GnRH treatment ranges from 67% to 87% depending on the administration dose [9] . However, Nessan et al. [30] reported a pregnancy rate of 40% with the administration of GnRH. Similarly, Probo et al. [32] reported no statistical difference between the regression rates of luteal and follicular cysts and the pregnancy rates achieved with GnRH administration. In this study, the OPR resulting from this treatment regimen was 53.3%.
In fact, in large-sized herds, follicular and luteal cysts are not differentiated and all ovarian cysts are generally treated with GnRH and PGF2α combinations [15] . It was observed that GnRH and PGF2β administrations increased the ovulation rate (79.7% vs. 17.2%) and caused lower cystic persistence and pregnancy rates [26] . Stevenson and Tiffany [37] used Ovsynch protocol as a treatment for ovarian cysts and found it to be effective in curing the cystic condition. However, several researchers have reported low pregnancy rates around 25% to be obtained in cows treated with the Ovsynch protocol for the cows with ovarian cysts [7, 28] . The differences observed in the Ovsynch protocol applications arises from the administration time of PGF2α whether the progesterone level is either high or low, depending on the age of the corpus luteum [38, 44] .
In the present study, GnRH and PGF2α were administered together as a combination, and as a result of this combined use, higher percentages were obtained for both pregnancy rate and fertility parameters in GI and GII, in comparison to the group administered with GnRH alone (TSR was determined as 62.96% in GI, 56% in GII and 33.3% in GIII). The highest OPR (85%) and FSPR (40%) were obtained in GI. It is not possible to perform ultrasonography and test serum or milk P4 values in order to particularly establish the characteristics of the cyst (luteal or follicular) in every animal especially in large herds. Better outcome from combination therapy (GnRH and PGF2α) may be due to the fact that luteal thickening in the walls of cysts was determined by ultrasonography, but P4 values were not identified immediately and the treatments were not categorized in accord with these values. The studies also looked at P4 values not at the time of treatment but after samples were stored. In practice, since the analysis of P4 values immediately after the controls or parallel to these controls is not a common method, positive impact of this treatment, which is used for the possibility of both luteal and follicular cysts, on the fertility parameters indicates that it is a feasible treatment modality. In addition, a large proportion of cows with ovarian cysts treated with GnRH did not respond, probably because other follicles capable of responding to GnRH were not present [39] .
No statistically significant differences were determined between GI and GII concerning the fertility parameters investigated, however numerical and proportional differences were observed. In the scope that the numbers of animals included in the study groups being close to each other, the OPR being higher and DT-PD as well as the fertility parameters such as the PI and OPI being lower in GI, revealed positive differences to have occurred in the group, which received βC. TSR was higher in GI (62.96%) than GII (56%) and GIII (33.3%). Additional βC adminidtration to the treatment in GI resulted in the achievement of a OPR. Similarly to the findings of a study in which βC + PGF2β used for the treatment of ovarian disorders in dairy cows [14] . Treatments were done in first 120 days of postpartum period in this study and FSPR was found to be proportionally higher in βC administrated cows in GI. Likewise Arachiga et al. [2] reported increased pregnancy rates after βC supplementation in heat stressed cows on day 120 postpartum.
βC is known as an antioxidant which is eliminating the reactive oxygen species in the follicle and uterus in adequate quantities and effecting positively on reproductive status by its immunostimulator caharacter in dairy cows [12, 20] . Several researchers have reported the reproductive performance of cows with high serum βC levels to be higher [6, 22] . On the other hand, some other researchers have suggested that βC has no impact on fertility [16, 45] . It was reported that plasma βC levels were lower in cows with ovarian cysts [21] . Serum βC levels increased especially after the βC administrations on days 15 and 45 postpartum [4] . In this study, no difference were determined in the βC levels of the cows in the groups on day 0. On the other hand, βC levels were significantly higher on day 7 and 14 after treatment in GI which were administered βC additionally to the treatment protocol for ovarian cysts (P < 0.05). This statistical difference suggests that administration of βC in combination therapy is also effective in the treatment of ovarian cysts.
It is indicated that in cows with low serum βC levels, the development of the corpus luteum after oestrus occurs more slowly, formation of it is delayed, thus low production of P4 realized [3, 17] . While some researchers have demonstrated that βC supplementation positively affects P4 levels [3, 17] , some others have reported βC supplementation shows no effect on the production of P4 [24, 43] . Ay et al. [5] determined that after the administration of βC, serum βC levels remained high for a period of approximately 14 days, and observed that this increase had no effect on the P4 levels. In the present study, the assessment of the alterations that occurred in the serum P4 levels during the treatment period of the ovarian cysts showed that no statistically significant difference existed between the study groups (P > 0.05). These results can be related to various factors such as season and free radicals during steroidogenesis [3, 17] . The additional administration of βC was determined to increase the rate of cystic regression on day 7, when compared to the groups that were not administered with βC. This effect was attributed to the formation of the CL being supported by βC and it is thought that the high ovarian activity after treatment, in other words the high level of cystic regression, was attributed to this combined administration.
It was found that serum P4 values increased in all treatment groups on day 7 after treatment depending on low (< 3.18 nmol/L) or high (> 3.18 nmol/L) pre-treatment P4 values. In two post-treatment measurements (days 7 and 14), reduced or increased post-treatment values show that administrations were effective on the ovarian activity. Although it has been shown that P4 values are high (> 3.18 nmol/L) in luteal cysts and low (< 3.18 nmol/L) in follicular cysts [29] , progesterone has an indirect effect on the development of ovarian cysts [36] . Considering the fact that other than progesterone, insulin concentration and other factors such as insulin-like growth factor-1 (IGF1), luteinizing hormone (LH) and estradiol-17β play a more effective role in the formation of ovarian cysts [18, 27] , it is suggested that post-administration changes in P4 values in all groups are not effective on fertility parameters. The different fertility results in the groups also indicate this.
Recent researches have shown that fertility is affected by subclinical ketosis or feed and dry matter intake in lactation and closure of the energy gap [8] . In the present study, the comparison of the study groups showed that the administration of βC in addition to a GnRH + PGF2α combination increased the success of the treatment regimen applied (GI 62.5%, GII 56% and GIII 33.3%). Several literature reports indicate that βC supplementation is of particular significance in dairys, where animal nutrition and green crop provision to the animals are either not done correctly or are inadequate [1, 3] .
CONCLUSIONS
In conclusion, it was determined that high pregnancy rates were obtained by the combined treatment of ovarian cysts (GnRH + PGF2α) and number of inseminations per conception was at desired limits. The achievement of better percentile and numerical fertility parameters in the group, which additionally received βC, demonstrated that, particularly in farms with non-optimal animal nutrition conditions and high numbers of infertility cases, βC supplementation could be a viable option for treatment. 2 Alke Health Products. Istanbul, Turkey. 3 Intervet Veteriner Ilaçlari. Istanbul, Turkey. 4 Alvetra und Werfft AG. Neumünster, Germany. 5 Duzen Laboratory Group. Ankara, Turkey. 6 SPSS Inc. Chicago, IL, USA.
